Maybe, but then you have a different financial model being played out with it being subscritpion based and no small fee either. This changes how it can be marketed and the pyrimid approach would not supprise me in that once the subscriptions level of, they offer them referal links in which they get $1 a month for people subscribing via their link after their extended trial period of say 90 days.

At least, that is what I would be looking at doing. Certainly the monthly fee is high, so what level they break even in running costs will be lower and may well be that they already break even in running and depreciation of assets -costs. May even be a small monthly profit already. We just don't know.